✦ LIBER ✦

Budget Impact Analysis Of The Introduction Of Saxagliptin/Metformin Extended-Release (Xr) In The Treatment Of Type-2 Diabetes In Chile

✍ Scribed by Elgart, JF; Gonzalez, L; Aiello, EC; Gagliardino, JJ

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Type 2 Diabetes with Saxagl

✍ Elgart, J.; Gonzalez, L.; Aiello, E.C.; Gagliardino, J.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

PDB20 BUDGET IMPACT ANALYSIS OF THE INTR

✍ J. Elgart; J. Caporale; E.C. Aiello; J.J. Gagliardino; M. Waschbusch; L. Jotimli 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PDB14 BUDGET IMPACT ANALYSIS OF THE INTR

✍ J Elgart; J Caporale; JJ Gagliardino; M Waschbusch; EC Aiello; L Jotimliansky 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Metformin extended release for the treat

✍ Schwartz, Sherwyn L; Wu, Jacqueline F; Berner, Bret 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 115 KB

PDB19 BUDGET IMPACT ANALYSIS OF SAXAGLIP

✍ A Juarez-Garcia; G Martinez-Rivera; P Anaya; BM Donato 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PDB27 COST-EFFECTIVENESS ANALYSIS OF MET

✍ J. Elgart; J. Caporale; E.C. Aiello; M. Waschbusch; L. Jotimliansky; J.J. Gaglia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB